drugset / Trial / NCT00171262

Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers

NCT00171262

Phase 4 Completed 120 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

To analyze efficacy of fluvastatin on patients with chronic renal disease by analyzing certain inflammatory markers. In addition, tolerability and safety will also be evaluated in a Spanish population.

Timeline

Start
2004-08
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified

Indications